… However, MGMT methylation status does not always … MGMT promoter methylation improves
response to alkylating therapy is still unknown. MGMT promoter methylation status testing is …

… , our study highlights an opportunity to increase MGMT testing nationwide for oligodendroglial
tumors. However, widespread adoption will likely not be realized until further guidance is …

… In this Cochrane Review, we aimed to assess which way of measuring methylation of the
MGMT promoter best predicts survival for people with glioblastoma who are treated with …

… focuses on comparing MGMT promoter methylation status of various patients with their survival
time of … Associations of clinical data and MGMT promoter status were tested by χ 2 tests. …

… MGMT promoter methylation and TERT promoter mutation on glioma patients’ overall survival
(… As a result, it is crucial to test for TERT promoter mutation and MGMT methylation in GBM …

… Then, we compared the PFS and overall survival (OS) of patients in different methylation
groups of … We additionally compared the predictive cutoff levels of MGMT promoter PSQ testing …

… MGMT methylation and overall survival and evaluated the interaction between MGMT
methylation … We did not report P-values in descriptive tables to avoid multiple testing. We used the …

… of MGMT promoter methylation in patients with grade 3 gliomas is less clear. The purpose of
the present study was to evaluate the utilization of MGMT testing … improved overall survival …

… were tested for MGMT-promoter methylation status before … the role of MGMT-promoter
methylation status in predicting the … was progression-free survival (PFS) by MGMT-promoter …

… poor prognosis and overall survival (OS), commonly less than two years with a 5.6% 5-year …
cutoff value for determining MGMT promoter methylation status by PSQ testing will allow for …